For instance, expression of RIPK3 and other necroptotic adapters in tumor cells was associated with improvement in CD8+ T cell infiltration in hepatocellular carcinoma [17], cholangiocarcinoma [18], and prostate cancer [19]. Here, RIPK3 is linked to neoplasm.